Dr. David Gudis, MD

Dr. Gudis practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Gudis' NPI, 1699939249, was assigned on July 14, 2008. Dr. Gudis graduated from Perelman School of Medicine - Philadelphia in 2008. Dr. Gudis holds New York license 278963.

Dr. Gudis' primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Gudis' primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Gudis is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Gudis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gudis practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Gudis' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Gudis is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Gudis' licenses on file in 3 states: New York, South Carolina and Pennsylvania.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders and endoscopic sinus surgery among the conditions Dr. Gudis treats.

CMS data shows 690 Medicare services from Dr. Gudis across 9 procedure codes in 2024, for 245 Medicare patients. Medicare paid $116,624 for them.

CMS counts 245 Medicare patients who saw Dr. Gudis in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gudis' median patient age at 48, with 51% women.

In 2024, Dr. Gudis wrote 514 Medicare Part D claims for 157 patients. 99% of them were for generic drugs. CMS names the drug for 454 of them, across 4 drugs with 11 or more claims each, at $6,067 in total drug cost. In 2023, CMS named 493 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gudis for performance year 2024, reported through an alternative payment model (APM). Dr. Gudis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gudis as offering telehealth.

Dmand AI links 140 papers to Dr. Gudis, published from 2013 to 2025. 2021 was the busiest year, with 28. The most frequent topics are Endoscopy, Rhinitis and Sinusitis. Dr. Gudis has published most often in Int Forum Allergy Rhinol. Dr. Gudis' most frequent co-authors are Jonathan Brett Overdevest, MD, PhD, Zachary Michael Soler, MD and Emily Ann Dimango, MD.

CMS Open Payments shows 60 general payments to Dr. Gudis from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $3,914.

Dmand AI lists 5 awards for Dr. Gudis, most recently Golden Endoscope Award in 2021. Dr. Gudis serves on Humanitarian Committee AAO-HNS, Paranasal Sinus Committee AAO-HNS and Pediatric Committee ARS.

Dr. Gudis graduated from Perelman School of Medicine - Philadelphia in 2008. Dr. Gudis is a member of NHS, American Cleft Palate-Craniofacial Association and North American Skull Base Society.

Dr. Gudis is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.